Nuvation Bio has delivered a very large 211.1% share price gain over the past three years, even as the stock has recently pulled back. That kind of longer term move puts a spotlight on a basic question for you as an investor: whether the current valuation is supported by the company’s sales profile. Over a three year window the stock is up 211.1%, so anyone looking at Nuvation Bio today needs to ask how much of its commercial potential is already reflected in the price. Recent product...
Motley Fool Press Release.
Tipranks Press Release.
Detailed price information for Nuvation Bio Inc (NUVB-N) from The Globe and Mail including charting and trades.
Nuvation Bio NUVB) stock and Jazz Pharmaceuticals (JAZZ) stock gain as Citi issues new Buy ratings on the firms based on their cancer treatments. Read more here.
Nuvation Bio (NUVB) has an average rating of buy and mean price target of $13.10, according to analy
Nuvation Bio (NYSE:NUVB) presented new subgroup analyses of IBTROZI (taletrectinib) at the 2026 World Conference on Lung Cancer. The data indicated durable and consistent efficacy in advanced ROS1+ non small cell lung cancer regardless of prior chemotherapy exposure. IBTROZI efficacy was reported as consistent across different ROS1 fusion partners in patients with advanced ROS1+ non small cell lung cancer. These IBTROZI subgroup findings matter, but investors may wish to weigh them alongside...
"Mad Money" host Jim Cramer rings the lightning round bell, which means he's giving his answers to callers' stock questions at rapid speed.
The average of price targets set by Wall Street analysts indicates a potential upside of 91.9% in Nuvation Bio (NUVB). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.
Nuvation Bio (NUVB) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
This is the newest page. Registered accounts read further back.